Motus GI to go public with $25M IPO — 3 insights

Motus GI will sell 4.25 million shares of its common stock at $6 per share as it attempts to raise $25.5 million through a U.S.-based initial public offering, Seeking Alpha reports.

Advertisement
By: Staff

Here’s what you should know:

1. Motus GI developed the Pure-Vu System, which assists with colonoscopy preparation.

2. Motus does not yet have a reimbursement code for the Pure-Vu system, and thus needs the public offering to raises funds for further clinical trials.

3. Motus will trade under the symbol MOTS.

More articles on gastroenterology: 
Physicians Endoscopy, Exact Sciences & more — 6 GI company key notes
How Anthem’s new anesthesia policy for cataract surgery will affect ASCs — 5 insights
Dr. Brad Cohen replaces hip of celebrity chef Jeffrey Strauss — 4 insights

The future of perioperative care: Orchestrating efficiency across every role

Recommended Whitepaper

Advertisement

Next Up in GI & Endoscopy

  • Is high acuity the new normal in GI?

    As colonoscopy demand rises, driven in part by more diagnostic referrals for patients under 55, GI leaders are also seeing…

    By: Patsy Newitt

  • ConMed to end its GI product lines

    Medical device company and surgical equipment manufacturer ConMed plans to exit its gastroenterology product lines.  ConMed’s gastroenterology segment is projected…

    By: Cameron Cortigiano
Advertisement

Comments are closed.